EU clears Pfizer’s $43 bn takeover of biotech firm Seagen

by

The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer’s $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.

Leave A Comment

Your email address will not be published. Required fields are marked *